Atsuko Mugitani

The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen, Yukiko Matsunaga, Kana Hasegawa et al. · Nature Medicine · 2017 · 139 citations

Cancer Immunosurveillance, Immunology, Cellular Immune Response +5

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

Naoki Hosen, Yoshikazu Matsuoka, Satoshi Kishida et al. · Leukemia · 2012 · 75 citations · Full text

Hematological Malignancy, Immunology, Hematology +6

Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma

Yoshiki Terada, Hirohisa Nakamae, Ran Aimoto et al. · Journal of Experimental & Clinical Cancer Research · 2009 · 65 citations · Full text

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest

Kaori Makita, Kensuke Ohta, Atsuko Mugitani et al. · Bone Marrow Transplantation · 2003 · 56 citations

Transplantation, Marrow Transplantation, Stem Cell Transplantation +10

CD48 as a novel molecular target for antibody therapy in multiple myeloma

Naoki Hosen, Hiroyoshi Ichihara, Atsuko Mugitani et al. · British Journal of Haematology · 2011 · 49 citations · Full text